Trial Profile
Improving Cone-beam Computed Tomography for Image Guided Stereotactic Body Radiation Therapy of the Liver Using Gadoxetate Disodium
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 29 Jan 2021
Price :
$35
*
At a glance
- Drugs Gadoxetate disodium (Primary)
- Indications Liver cancer
- Focus Diagnostic use; Proof of concept
- 25 Jan 2021 Status changed from not yet recruiting to withdrawn prior to enrolment as study was not approved.
- 17 Jul 2017 New trial record